Plan your Türkiye operation around the study lifecycle

15–25 °C · Multi-site programme

Nationwide supply for a smoking-cessation programme

Project scope224 centres · 164,733 participants · 247,435 medicine boxes

The project summary records medicine supply at 15–25 °C across a network involving 400 physicians and 650 assistant healthcare personnel. The box and participant figures belong to this past programme.

For sponsors: Site-level demand, stock units and the delivery calendar should be defined together at the start of scoping.

Distribution service →

15–25 °C · Early access

Physician deliveries in an early-access programme

Project scope73 physicians · 900 medicines · 15–25 °C

A separate early-access summary reports that medicines held at ambient temperature were delivered to 73 physicians. Unlike multi-site study distribution, this example centres on a physician-level recipient plan.

For sponsors: Confirm the physician list, product quantity and authorised recipient before finalising dispatch.

Distribution service →

2–8 °C · Phase 3

Coronovac Phase 3

Project scope24 sites · 26,180 vaccines · 2–8 °C

The Coronovac Phase 3 summary records a 24-site scope for vaccines with a 2–8 °C temperature profile. This quantity belongs to this Phase 3 study alone and is not combined with the other vaccine projects.

For sponsors: Site allocation and cold-chain requirements should be specified for each study and shipment plan.

Storage service →

2–8 °C · Phase 3

Turkovac Phase 3

Project scope8 sites · 1,290 people × 2 administrations · 2,580 vaccines

The Turkovac Phase 3 summary lists 2,580 vaccines for two administrations to 1,290 people across eight sites under a 2–8 °C profile. Participant, administration and product counts are distinct planning inputs.

For sponsors: Calculate product demand from the administration schedule, not the site count alone.

Storage service →

2–8 °C · Phase 2b

Rapel Phase 2b

Project scope41 sites · 4,340 vaccines · 2–8 °C

The Rapel Phase 2b summary records 4,340 vaccines across a 41-site study scope under a 2–8 °C profile. The breadth of the site network is a planning variable separate from product quantity.

For sponsors: Prepare site-level demand, delivery windows and recipient contacts separately.

Storage service →

15–25 °C · Non-drug study

Research material for a non-drug clinical study

Project scope14 sites · 4,484 boxes · 15–25 °C

The summary of a clinical study described as non-drug records 4,484 boxes of research material for 14 sites under a 15–25 °C profile. The product is not labelled as a medicine or medical device without a separate classification check.

For sponsors: State the product classification, box/stock unit and site allocation in the initial brief.

Distribution service →

International routes · Urgent coordination

Urgent international product shipments

Project scope6 routes · 28–35 hours from origin to destination

Past shipment summaries originating in New Delhi, London, Beijing, New York, Hong Kong and Shanghai cover cell-therapy material, research medicines, kits and consumables. The recorded times run from origin to destination; they are not customs-clearance durations.

For sponsors: For an urgent request, share product class, permit status, origin and target delivery time on one timeline.

Customs coordination →

Site activation · Equipment and calibration

Equipment support for clinical sites

Project scope7 sites · more than 50 calibration services

The project summary lists ultra-low freezers, incubators, vaccine refrigerators and centrifuges sourced for seven sites. The same document separately reports more than 50 calibration services; device and calibration counts are not combined as one delivery total.

For sponsors: Define technical needs, installation conditions and calibration ownership for each site at the outset.

Equipment and supply sourcing →